KAIST Identifies Multiple Viruses and Variants Simultaneously by Controlling the “Speed” of CRISPR Gene Scissors​
en-GBde-DEes-ESfr-FR

KAIST Identifies Multiple Viruses and Variants Simultaneously by Controlling the “Speed” of CRISPR Gene Scissors​


As the spread of infectious diseases accelerates, technologies that can accurately distinguish multiple viruses in a single test are becoming increasingly important. KAIST and an international research team have developed a new diagnostic technology that simultaneously identifies various viruses and variants by controlling the “speed” of gene scissors. This technology is expected to transform responses to emerging infectious diseases, as it can detect multiple infections at once while reducing the complexity of testing procedures.

KAIST (President Kwang Hyung Lee) announced on the 26th of April that a research team led by Professor Sungmin Son from the Department of Bio and Brain Engineering, in collaboration with researchers from the University of California, Berkeley (UC Berkeley) and the Gladstone Institutes, has developed a new ribonucleic acid (RNA) diagnostic technology that can distinguish multiple viruses and variants simultaneously by utilizing the reaction speed of gene scissors.

The tool used by the research team is a CRISPR-based protein called Cas13. Gene scissors are proteins that locate and cut specific genetic material, becoming activated when they recognize their target. Cas13 specifically targets RNA. When it finds its target, it becomes activated and cuts surrounding RNA, generating a fluorescent signal.

Existing technologies require the use of different gene scissors or various fluorescent colors to detect multiple viruses simultaneously, making the system complex and difficult to apply in real-world settings.

The research team took a different approach. They focused on the fact that when gene scissors bind to their target, the speed of “cutting” varies depending on the type of virus. By observing at the single-molecule level within tiny droplets, they confirmed that unique reaction speed patterns emerge depending on the combination of guide RNA and target RNA. Guide RNA is an RNA molecule that provides “positional information,” guiding the gene scissors to their target.
Based on this, the research team developed a “kinetic barcoding” technology that uses differences in reaction speed like a barcode. This method interprets reaction speeds as signal patterns to distinguish different viruses. Through this technology, it became possible to simultaneously identify multiple viruses and variants using only a single type of gene scissors.

In addition, by adjusting the design of guide RNA, the cutting speed of gene scissors can be tuned, enabling scalable and simultaneous detection of a wide range of viruses.

The testing process has also been greatly simplified. In conventional methods, detecting RNA viruses requires a “reverse transcription” process that converts RNA into DNA, but this technology enables direct detection of RNA as it is. Reverse transcription is a step that increases testing time and complicates procedures.

When tested on actual clinical samples, the technology successfully distinguished various respiratory viruses and SARS-CoV-2 variants in a single reaction.

Professor Sungmin Son stated, “This study goes beyond simply determining whether a virus is present, and is the first case to use the reaction speed of gene scissors as a new form of diagnostic information,” adding, “It will become a next-generation platform capable of diagnosing various infectious diseases at once in the field.”

This study was led by Professor Sungmin Son of KAIST as the first author and co-corresponding author, and was published on March 31, 2026, in the world-renowned journal in bioengineering, Nature Biomedical Engineering.
※ Paper title: “Programmable kinetic barcoding for multiplexed RNA detection with Cas13a,” DOI: 10.1038/s41551-026-01642-6

This research was supported by KAIST’s New Faculty Settlement Research Fund and by the U.S. National Institutes of Health (NIH/NIAID).

Attached files
Regions: Asia, South Korea
Keywords: Applied science, Engineering, Technology, Health, Medical, People in health research, Science, Life Sciences

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonials

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...


  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by AlphaGalileo Terms Of Use Privacy Statement